Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -8.76% | -14.53% | +33.70% |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.70% | 91.19M | |
+4.54% | 111B | |
+11.60% | 105B | |
-12.82% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.02% | 16.96B | |
+3.54% | 13.7B | |
+37.74% | 12.45B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- BTIG Adjusts Passage Bio's Price Target to $16 From $25, Reiterates Buy Rating